Section 11.1 of 21 CFR Part 11 ties its scope to records that other FDA regulations already require you to keep.
Those regulations are the predicate rules: 21 CFR 211 for drug manufacturing, 820 for devices, and so on. FDA's 2003 guidance on Part 11 scope and application confirmed the narrow reading, covering records a predicate rule requires plus records submitted to the agency.
For a BMS or EMS, that becomes work on the points list: name the rule that requires each point's record. Room pressure differentials, temperature and RH in classified rooms, and particle counts used in batch release usually have one. Office comfort loops, chiller sequencing and most control setpoints usually do not, unless someone uses them for a GMP decision.
The list usually splits into a small GMP-critical set and a large plant-control set. Many plants move the first into a validated EMS with audit trail, access control and electronic signatures, and leave the BMS to run the plant. A whole BMS under Part 11 controls costs more to validate.
Plants exporting to Europe need one more step. EU GMP Annex 11 has no predicate-rule test; it covers computerized systems used in GMP activities, scaled by risk. The split still helps, but the BMS needs a documented risk assessment.
We write that split into the URS for monitoring and SCADA systems, before the platform is chosen.
Topics
Industries




